HEADER APOPTOSIS 29-JUN-22 7YB7 TITLE ANTI-APOPTOTIC PROTEIN BCL-2-M12 COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2,BCL-2-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: BCL2-L-1,APOPTOSIS REGULATOR BCL-X; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CP2 PEPTIDE; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES; COMPND 10 OTHER_DETAILS: THIS IS A CYCLIC PEPTIDE, WITH A SPECIAL LINKER IQ8 COMPND 11 CONNECTED WITH A AND C. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2, BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS BCL-2, M12 MUTANTS, ANTI-APOPTOTIC, CYCLIC PEPTIDE, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR F.W.LI,C.LIU,D.L.WU REVDAT 2 28-FEB-24 7YB7 1 JRNL REVDAT 1 15-NOV-23 7YB7 0 JRNL AUTH F.LI,J.LIU,C.LIU,Z.LIU,X.PENG,Y.HUANG,X.CHEN,X.SUN,S.WANG, JRNL AUTH 2 W.CHEN,D.XIONG,X.DIAO,S.WANG,J.ZHUANG,C.WU,D.WU JRNL TITL CYCLIC PEPTIDES DISCRIMINATE BCL-2 AND ITS CLINICAL MUTANTS JRNL TITL 2 FROM BCL-X L BY ENGAGING A SINGLE-RESIDUE DISCREPANCY. JRNL REF NAT COMMUN V. 15 1476 2024 JRNL REFN ESSN 2041-1723 JRNL PMID 38368459 JRNL DOI 10.1038/S41467-024-45848-1 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 29689 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.194 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1656 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2105 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.90 REMARK 3 BIN R VALUE (WORKING SET) : 0.1940 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.2420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2436 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 261 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.18000 REMARK 3 B22 (A**2) : 0.20000 REMARK 3 B33 (A**2) : -0.39000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.150 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.132 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.084 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.256 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.946 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2542 ; 0.014 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2241 ; 0.001 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3437 ; 1.961 ; 1.653 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5119 ; 1.553 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 288 ; 5.376 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 163 ;33.836 ;21.779 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 392 ;17.786 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;22.242 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 298 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2908 ; 0.012 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 680 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1174 ; 3.606 ; 3.025 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1173 ; 3.593 ; 3.026 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1456 ; 5.123 ; 4.504 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1457 ; 5.121 ; 4.503 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1364 ; 5.797 ; 3.676 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1364 ; 5.796 ; 3.676 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1980 ; 8.853 ; 5.269 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 10665 ;11.228 ;57.158 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 10477 ;11.252 ;56.874 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 2 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A B 4587 0.09 0.05 REMARK 3 2 C D 298 0.12 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7YB7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1300030593. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-22 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29689 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 20.00 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 22.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 71.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5 M AMMONIUM SULFATE, 0.1 M SODIUM REMARK 280 CITRATE TRIBASIC DIHYDRATE PH 5.6, 1.0 M LITHIUM SULFATE REMARK 280 MONOHYDRATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.76250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.76250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 52.38050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.39400 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 52.38050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.39400 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.76250 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 52.38050 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 52.39400 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.76250 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 52.38050 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 52.39400 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 23 REMARK 465 ALA A 24 REMARK 465 GLY A 25 REMARK 465 ASP A 26 REMARK 465 VAL A 27 REMARK 465 GLU A 28 REMARK 465 GLU A 29 REMARK 465 ASN A 30 REMARK 465 ARG A 31 REMARK 465 THR A 32 REMARK 465 GLU A 33 REMARK 465 ALA A 34 REMARK 465 PRO A 35 REMARK 465 GLU A 36 REMARK 465 GLY A 37 REMARK 465 THR A 38 REMARK 465 ALA B 24 REMARK 465 GLY B 25 REMARK 465 ASP B 26 REMARK 465 VAL B 27 REMARK 465 GLU B 28 REMARK 465 GLU B 29 REMARK 465 ASN B 30 REMARK 465 ARG B 31 REMARK 465 THR B 32 REMARK 465 GLU B 33 REMARK 465 ALA B 34 REMARK 465 PRO B 35 REMARK 465 GLU B 36 REMARK 465 GLY B 37 REMARK 465 THR B 38 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 220 O HOH A 255 1.51 REMARK 500 O HOH B 206 O HOH B 303 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 102 CD GLU A 102 OE1 0.066 REMARK 500 CYS C 12 C CYS C 12 O 0.135 REMARK 500 CYS D 12 C CYS D 12 O 0.118 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS C 12 CA - C - O ANGL. DEV. = -25.4 DEGREES REMARK 500 CYS D 12 CA - C - O ANGL. DEV. = -19.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 68 65.95 -102.63 REMARK 500 LEU A 69 -63.81 -99.89 REMARK 500 REMARK 500 REMARK: NULL DBREF 7YB7 A 2 27 UNP P10415 BCL2_HUMAN 10 35 DBREF 7YB7 A 28 41 UNP Q07817 B2CL1_HUMAN 31 44 DBREF 7YB7 A 42 153 UNP P10415 BCL2_HUMAN 92 203 DBREF 7YB7 B 2 27 UNP P10415 BCL2_HUMAN 10 35 DBREF 7YB7 B 28 41 UNP Q07817 B2CL1_HUMAN 31 44 DBREF 7YB7 B 42 153 UNP P10415 BCL2_HUMAN 92 203 DBREF 7YB7 C 2 12 PDB 7YB7 7YB7 2 12 DBREF 7YB7 D 2 12 PDB 7YB7 7YB7 2 12 SEQADV 7YB7 MET A 1 UNP P10415 INITIATING METHIONINE SEQADV 7YB7 SER A 12 UNP P10415 HIS 20 ENGINEERED MUTATION SEQADV 7YB7 GLN A 45 UNP P10415 LEU 95 ENGINEERED MUTATION SEQADV 7YB7 LEU A 56 UNP P10415 ARG 106 ENGINEERED MUTATION SEQADV 7YB7 GLY A 74 UNP P10415 PHE 124 ENGINEERED MUTATION SEQADV 7YB7 TYR A 77 UNP P10415 ARG 127 ENGINEERED MUTATION SEQADV 7YB7 ALA A 78 UNP P10415 GLY 128 ENGINEERED MUTATION SEQADV 7YB7 SER A 79 UNP P10415 ARG 129 ENGINEERED MUTATION SEQADV 7YB7 VAL A 118 UNP P10415 PRO 168 ENGINEERED MUTATION SEQADV 7YB7 ALA A 125 UNP P10415 LEU 175 ENGINEERED MUTATION SEQADV 7YB7 ALA A 128 UNP P10415 THR 178 ENGINEERED MUTATION SEQADV 7YB7 THR A 129 UNP P10415 GLU 179 ENGINEERED MUTATION SEQADV 7YB7 ASP A 133 UNP P10415 ARG 183 ENGINEERED MUTATION SEQADV 7YB7 MET B 1 UNP P10415 INITIATING METHIONINE SEQADV 7YB7 SER B 12 UNP P10415 HIS 20 ENGINEERED MUTATION SEQADV 7YB7 GLN B 45 UNP P10415 LEU 95 ENGINEERED MUTATION SEQADV 7YB7 LEU B 56 UNP P10415 ARG 106 ENGINEERED MUTATION SEQADV 7YB7 GLY B 74 UNP P10415 PHE 124 ENGINEERED MUTATION SEQADV 7YB7 TYR B 77 UNP P10415 ARG 127 ENGINEERED MUTATION SEQADV 7YB7 ALA B 78 UNP P10415 GLY 128 ENGINEERED MUTATION SEQADV 7YB7 SER B 79 UNP P10415 ARG 129 ENGINEERED MUTATION SEQADV 7YB7 VAL B 118 UNP P10415 PRO 168 ENGINEERED MUTATION SEQADV 7YB7 ALA B 125 UNP P10415 LEU 175 ENGINEERED MUTATION SEQADV 7YB7 ALA B 128 UNP P10415 THR 178 ENGINEERED MUTATION SEQADV 7YB7 THR B 129 UNP P10415 GLU 179 ENGINEERED MUTATION SEQADV 7YB7 ASP B 133 UNP P10415 ARG 183 ENGINEERED MUTATION SEQRES 1 A 153 MET ASP ASN ARG GLU ILE VAL MET LYS TYR ILE SER TYR SEQRES 2 A 153 LYS LEU SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP SEQRES 3 A 153 VAL GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SEQRES 4 A 153 SER GLU VAL VAL HIS GLN THR LEU ARG GLN ALA GLY ASP SEQRES 5 A 153 ASP PHE SER LEU ARG TYR ARG ARG ASP PHE ALA GLU MET SEQRES 6 A 153 SER SER GLN LEU HIS LEU THR PRO GLY THR ALA TYR ALA SEQRES 7 A 153 SER PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY SEQRES 8 A 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY SEQRES 9 A 153 GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER SEQRES 10 A 153 VAL LEU VAL ASP ASN ILE ALA ALA TRP MET ALA THR TYR SEQRES 11 A 153 LEU ASN ASP HIS LEU HIS THR TRP ILE GLN ASP ASN GLY SEQRES 12 A 153 GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY SEQRES 1 B 153 MET ASP ASN ARG GLU ILE VAL MET LYS TYR ILE SER TYR SEQRES 2 B 153 LYS LEU SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP SEQRES 3 B 153 VAL GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SEQRES 4 B 153 SER GLU VAL VAL HIS GLN THR LEU ARG GLN ALA GLY ASP SEQRES 5 B 153 ASP PHE SER LEU ARG TYR ARG ARG ASP PHE ALA GLU MET SEQRES 6 B 153 SER SER GLN LEU HIS LEU THR PRO GLY THR ALA TYR ALA SEQRES 7 B 153 SER PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY SEQRES 8 B 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY SEQRES 9 B 153 GLY VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER SEQRES 10 B 153 VAL LEU VAL ASP ASN ILE ALA ALA TRP MET ALA THR TYR SEQRES 11 B 153 LEU ASN ASP HIS LEU HIS THR TRP ILE GLN ASP ASN GLY SEQRES 12 B 153 GLY TRP ASP ALA PHE VAL GLU LEU TYR GLY SEQRES 1 C 11 ALA PRO ILE ARG TYR GLU TRP ASP GLU PHE CYS SEQRES 1 D 11 ALA PRO ILE ARG TYR GLU TRP ASP GLU PHE CYS HET IQ8 C 101 20 HET IQ8 D 101 20 HETNAM IQ8 N-(2-ACETAMIDOETHYL)-4-(4,5-DIHYDRO-1,3-THIAZOL-2-YL) HETNAM 2 IQ8 BENZAMIDE FORMUL 5 IQ8 2(C14 H17 N3 O2 S) FORMUL 7 HOH *261(H2 O) HELIX 1 AA1 ASP A 2 GLN A 17 1 16 HELIX 2 AA2 SER A 40 TYR A 58 1 19 HELIX 3 AA3 TYR A 58 SER A 66 1 9 HELIX 4 AA4 THR A 75 ARG A 89 1 15 HELIX 5 AA5 ASN A 93 ARG A 114 1 22 HELIX 6 AA6 VAL A 118 LEU A 135 1 18 HELIX 7 AA7 LEU A 135 ASN A 142 1 8 HELIX 8 AA8 GLY A 143 GLY A 153 1 11 HELIX 9 AA9 ASP B 2 GLN B 17 1 16 HELIX 10 AB1 SER B 40 TYR B 58 1 19 HELIX 11 AB2 TYR B 58 SER B 67 1 10 HELIX 12 AB3 THR B 75 ARG B 89 1 15 HELIX 13 AB4 ASN B 93 ARG B 114 1 22 HELIX 14 AB5 GLU B 115 SER B 117 5 3 HELIX 15 AB6 VAL B 118 LEU B 135 1 18 HELIX 16 AB7 LEU B 135 ASN B 142 1 8 HELIX 17 AB8 GLY B 143 GLY B 153 1 11 HELIX 18 AB9 TYR C 6 GLU C 10 5 5 HELIX 19 AC1 TYR D 6 GLU D 10 5 5 LINK C ALA C 2 C19 IQ8 C 101 1555 1555 1.62 LINK SG CYS C 12 C20 IQ8 C 101 1555 1555 1.94 LINK C ALA D 2 C19 IQ8 D 101 1555 1555 1.65 LINK SG CYS D 12 C20 IQ8 D 101 1555 1555 1.94 CRYST1 104.761 104.788 111.525 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009546 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009543 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008967 0.00000